Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptionally inactive ATF2 variant drives melanomagenesis

ABSTRACT: Transcriptionally inactive ATF2 variant drives melanomagenesis

PROVIDER: PRJNA320278 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR3332284.fastq.gz	Fastqsanger.gz
	SRR3332285.fastq.gz	Fastqsanger.gz
	SRR3332286.fastq.gz	Fastqsanger.gz
	SRR3332287.fastq.gz	Fastqsanger.gz
	SRR3332288.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Transcriptionally inactive ATF2 variant drives melanomagenesis [Seq]

Project description:Characterized by striking metastatic propensity and chemoresistance, melanoma is among the most lethal cutaneous malignancies. The transcription factor ATF2 was shown to elicit oncogenic activities in melanoma, and its inhibition attenuates melanoma development. Here, a mouse model engineered to express a transcriptionally inactive form of Atf2 (Atf2?8,9) was found to be sufficient to induce nevi formation and, when crossed with BrafV600E animals, to promote melanoma development. The cross of Atf2?8,9 with BrafV600E;Pten-/- mice augmented pigmentation, tumorigenicity, and metastasis. Similar to mouse Atf2?8,9, the human ATF2 splice variant 5 enhanced growth and migration capacity of cultured melanoma and immortalized melanocytes. Induced Melan-A, CXCL9, S100A8, CCR7 expression, seen in Atf2?8,9-driven tumors associate with their enhanced pigmentation, immune infiltration and propensity to metastasize. Notably, elevated ATF2SV5 expression in melanoma specimens coincided with poor prognosis. The gain-of-function activity elicited by the truncated ATF2 form offers unexpected insight into mechanisms underlying melanoma development and progression.

2016-04-29 | GSE79917 | GEO

Transcriptionally inactive ATF2 variant drives melanomagenesis [Array]

2016-05-02 | GSE81013 | GEO

A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis.

Project description:Melanoma is one of the most lethal cutaneous malignancies, characterized by chemoresistance and a striking propensity to metastasize. The transcription factor ATF2 elicits oncogenic activities in melanoma, and its inhibition attenuates melanoma development. Here, we show that expression of a transcriptionally inactive form of Atf2 (Atf2(?8,9)) promotes development of melanoma in mouse models. Atf2(?8,9)-driven tumors show enhanced pigmentation, immune infiltration, and metastatic propensity. Similar to mouse Atf2(?8,9), we have identified a transcriptionally inactive human ATF2 splice variant 5 (ATF2(SV5)) that enhances the growth and migration capacity of cultured melanoma cells and immortalized melanocytes. ATF2(SV5) expression is elevated in human melanoma specimens and is associated with poor prognosis. These findings point to an oncogenic function for ATF2 in melanoma development that appears to be independent of its transcriptional activity.

| S-EPMC4889472 | biostudies-literature

Mus musculus

Project description:Transcriptionally inactive ATF2 variant drives melanomagenesis [Array]

| PRJNA320281 | ENA

Homo sapiens

Project description:Transcriptionally inactive ATF2 variant drives melanomagenesis [Seq]

| PRJNA317371 | ENA

Transcriptionally inactive ATF2 variant drives melanomagenesis

Project description:This SuperSeries is composed of the SubSeries listed below.

2016-05-02 | GSE81014 | GEO

Regulation of gene expression by ATF2 in mouse melanocytes

Project description:primary melanocytes from WT and ATF2 mutant (transcriptionally inactive) mice expressing the mutant N-ras transgene were prepared and assessed for changes in gene expression when maintained under normoxia and hypoxia growth conditions. 12 mouse melanocyte samples were analyzed during normoxia and hypoxia, with different ATF2 genotypes. The pivotal samples are represented as duplicates. Treatment of tamoxifen was used to induce recombination and expression of the mutant ATF2 (inducible Cre). Doxycyclin was used to induce expression of mutant N-Ras transgene.

2010-08-30 | E-GEOD-23860 | biostudies-arrayexpress

Regulation of gene expression by ATF2 in mouse melanocytes

2010-08-30 | GSE23860 | GEO

Transcriptionally regulated energy metabolism drives early erythropoiesis

Project description:Transcriptionally regulated energy metabolism drives early erythropoiesis

| PRJNA562552 | ENA

Transcriptionally regulated energy metabolism drives early erythropoiesis (RRBS)

Project description:Transcriptionally regulated energy metabolism drives early erythropoiesis (RRBS)

| PRJNA686370 | ENA